Por: The Hill Health October 24, 2022
Abbott Nutrition says it plans to build a new $500 million facility for specialty and metabolic infant formulas, amid calls from advocates and experts that there needs to be more domestic manufacturing and diversity in the supply chain. In an earnings call this week, the company said it also made leadership changes at its Sturgis, Mich., baby formula manufacturing plant as well as in its quality organization, following a shutdown and nationwide... + full article
CBS News USA Health October 22, 2022
Abbott plans to build a $500 million infant formula facility and is boosting production at other plants as the health care company looks to increase supply in the U.S. amid ongoing shortages.We're currently in the final stages of determining the site location and will work... + más
Abbott launches new infant formula recall at another plant for faulty bottle cap seals | ABC News
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch
Fox Business USA Business October 20, 2022
Check out what's clicking on FoxBusiness.com Abbott Laboratories CEO Robert Ford said Wednesday the company has made progress in addressing the ongoing baby formula shortage in the U.S. over the past several months, providing a status update and revealing changes aimed at... + más
CNN USA Health October 20, 2022
CNN — Abbott Nutrition plans to build a $500 million nutrition facility for specialty and metabolic infant formulas, Chairman and CEO Robert Ford said Wednesday. The announcement comes as the US formula shortage continues and experts have called for more domestic... + más
ABC News USA Health October 15, 2022
In a new recall following a separate one which dogged them for the better part of this year, Abbott, which has been the largest infant formula manufacturer in the U.S., is now voluntarily recalling bottles of their largest, most popular kind of formula, Similac, from their... + más
Abbott issues new baby formula recall over possibly spoiled products | 10 WBNS
The Hill USA Politics October 12, 2022
Sen. Elizabeth Warren (D-Mass.) sent a letter Wednesday to Abbott Nutrition accusing the company of employing “abusive legal tactics” to cover up health risks with its powdered infant formula product — safety concerns she said the business has been aware of for decades. In... + más
MarketWatch USA Business September 24, 2022
“The report also identifies several areas in which the FDA lacks specific authorities and resources. Simply put, if the FDA is expected to do more, it needs more,” he added. Supply-chain disruptions and product recalls from Abbott Laboratories in February due to... + más
FDA concedes delays in response to baby formula shortage | ABC News
Internal FDA report on infant formula crisis details shortfalls in response | ABC News
ABC News USA Health September 21, 2022
An internal review of the Food and Drug Administration's actions leading up to the finds a combination of human error, antiquated technology, and poor communication and accountability amongst an already threadbare food workforce all contributed to a perfect storm of... + más
FDA concedes delays in response to baby formula shortage | Associated Press
About iurex | Privacy Policy | Disclaimer |